Advancements in Treatment for Limited Stage Small Cell Lung Cancer: The Adriatic Trial

The chapter explores the Adriatic trial and its focus on improved standards for small cell lung cancer treatment, particularly in limited stage disease, aiming to enhance patient outcomes and prognosis through consolidated cancer immunotherapy post chemo radiation.